280 related articles for article (PubMed ID: 25710859)
1. Cross-sectional neurocognitive data do not support a transition from fibrofog to Alzheimer disease in fibromyalgia patients.
Leavitt F; Katz RS
J Clin Rheumatol; 2015 Mar; 21(2):81-5. PubMed ID: 25710859
[TBL] [Abstract][Full Text] [Related]
2. Fibromyalgia and cognition.
Glass JM
J Clin Psychiatry; 2008; 69 Suppl 2():20-4. PubMed ID: 18537459
[TBL] [Abstract][Full Text] [Related]
3. Distraction as a key determinant of impaired memory in patients with fibromyalgia.
Leavitt F; Katz RS
J Rheumatol; 2006 Jan; 33(1):127-32. PubMed ID: 16395760
[TBL] [Abstract][Full Text] [Related]
4. Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.
Kravitz HM; Katz RS
Rheumatol Int; 2015 Jul; 35(7):1115-25. PubMed ID: 25583051
[TBL] [Abstract][Full Text] [Related]
5. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
[TBL] [Abstract][Full Text] [Related]
6. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
de Jager CA
Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
Schönknecht P; Pantel J; Kruse A; Schröder J
Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
[TBL] [Abstract][Full Text] [Related]
8. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunction in fibromyalgia: slow access to the mental lexicon.
Leavitt F; Katz RS
Psychol Rep; 2014 Dec; 115(3):828-39. PubMed ID: 25539171
[TBL] [Abstract][Full Text] [Related]
10. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.
Geerlings MI; Jonker C; Bouter LM; Adèr HJ; Schmand B
Am J Psychiatry; 1999 Apr; 156(4):531-7. PubMed ID: 10200730
[TBL] [Abstract][Full Text] [Related]
11. Normalizing memory recall in fibromyalgia with rehearsal: a distraction-counteracting effect.
Leavitt F; Katz RS
Arthritis Rheum; 2009 Jun; 61(6):740-4. PubMed ID: 19479690
[TBL] [Abstract][Full Text] [Related]
12. Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline.
Perry RJ; Hodges JR
Dement Geriatr Cogn Disord; 2000; 11(6):342-9. PubMed ID: 11044780
[TBL] [Abstract][Full Text] [Related]
13. Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.
Walitt B; Čeko M; Khatiwada M; Gracely JL; Rayhan R; VanMeter JW; Gracely RH
Neuroimage Clin; 2016; 11():173-180. PubMed ID: 26955513
[TBL] [Abstract][Full Text] [Related]
14. Denial of memory deficit in Alzheimer's disease.
Sevush S; Leve N
Am J Psychiatry; 1993 May; 150(5):748-51. PubMed ID: 8480820
[TBL] [Abstract][Full Text] [Related]
15. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
[TBL] [Abstract][Full Text] [Related]
18. Premorbid proneness to distress and episodic memory impairment in Alzheimer's disease.
Wilson RS; Fleischman DA; Myers RA; Bennett DA; Bienias JL; Gilley DW; Evans DA
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):191-5. PubMed ID: 14742585
[TBL] [Abstract][Full Text] [Related]
19. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease.
Flicker C; Ferris SH; Reisberg B
J Geriatr Psychiatry Neurol; 1993; 6(2):84-96. PubMed ID: 8512635
[TBL] [Abstract][Full Text] [Related]
20. Cognitive function in fibromyalgia patients.
Park DC; Glass JM; Minear M; Crofford LJ
Arthritis Rheum; 2001 Sep; 44(9):2125-33. PubMed ID: 11592377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
